Published in
AME Publishing, Translational Lung Cancer Research, 9(11), p. 1809-1822, 2022
DOI: 10.21037/tlcr-22-139
Links
Tools
Development and validation of a polygenic hazard score to predict prognosis and adjuvant chemotherapy benefit in early-stage non-small cell lung cancer
Journal article published in 2022 by
Dan-Hua Li,
Yong-Qiao He,
Tong-Min Wang 
,
Wen-Qiong Xue,
Chang-Mi Deng,
Da-Wei Yang,
Wen-Li Zhang,
Zi-Yi Wu,
Lian-Jing Cao,
Si-Qi Dong,
Yi-Jing Jia,
Lei Yuan,
Lu-Ting Luo,
Yan-Xia Wu,
Xia-Ting Tong
and other authors.
,
Wen-Qiong Xue,
Chang-Mi Deng,
Da-Wei Yang,
Wen-Li Zhang,
Zi-Yi Wu,
Lian-Jing Cao,
Si-Qi Dong,
Yi-Jing Jia,
Lei Yuan,
Lu-Ting Luo,
Yan-Xia Wu,
Xia-Ting Tong
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 